Clinical Trial Update: Busulfan and Fludarabine Followed by Post-transplant Cyclophosphamide [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a conditioning regimen of busulfan and fludarabine followed by post-transplant cyclophosphamide in patients with hematologic malignanci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Multiple Myeloma

Drugs mentioned

• BUSULFAN (Busulfan)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Fludarabine (Fludarabine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Hematologic Diseases, Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2016-09-19